Aquestive Therapeutics
AQST
#7659
Rank
HK$3.40 B
Marketcap
HK$27.12
Share price
-6.61%
Change (1 day)
-39.07%
Change (1 year)

Earnings for Aquestive Therapeutics (AQST)

Earnings in 2026 (TTM): -HK$0.51 Billion

According to Aquestive Therapeutics 's latest financial reports the company's current earnings are HK$48.83 Million. In 2025 the company made an earning of -HK$0.53 Billion a decrease over its 2024 earnings that were of -HK$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aquestive Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.51 Billion-3.78%
2025 -HK$0.53 Billion143.96%
2024 -HK$0.22 Billion16669.33%
2023 -HK$1.28 Million-99.61%
2022 -HK$0.33 Billion-12.56%
2021 -HK$0.38 Billion12.24%
2020 -HK$0.34 Billion-24.89%
2019 -HK$0.45 Billion6.04%
2018 -HK$0.43 Billion4243.61%
2017 -HK$9.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.25 Billion 147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion-71.78%๐Ÿ‡บ๐Ÿ‡ธ USA